Invention Grant
- Patent Title: High dose radionuclide complexes for bone marrow treatment
- Patent Title (中): 高剂量放射性核素复合物用于骨髓治疗
-
Application No.: US12142664Application Date: 2008-06-19
-
Publication No.: US07696331B2Publication Date: 2010-04-13
- Inventor: Alan R. Fritzberg , Paul G. Abrams , Lauren Marie Tatalick , Kent R. Thoelke , James Kyle Bryan , Mark D. Hylarides , Elizabeth K. John
- Applicant: Alan R. Fritzberg , Paul G. Abrams , Lauren Marie Tatalick , Kent R. Thoelke , James Kyle Bryan , Mark D. Hylarides , Elizabeth K. John
- Applicant Address: US WA Seattle
- Assignee: Poniard Pharmaceuticals, Inc.
- Current Assignee: Poniard Pharmaceuticals, Inc.
- Current Assignee Address: US WA Seattle
- Agency: Schwegman, Lundberg & Woessner, P.A.
- Main IPC: C07F5/00
- IPC: C07F5/00
Abstract:
The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
Public/Granted literature
- US20090136419A1 HIGH DOSE RADIONUCLIDE COMPLEXES FOR BONE MARROW TREATMENT Public/Granted day:2009-05-28
Information query
